These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27826798)

  • 1. Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with Polypharmacy.
    Sugarman EA; Cullors A; Centeno J; Taylor D
    Drugs Aging; 2016 Dec; 33(12):929-936. PubMed ID: 27826798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
    Kim K; Magness JW; Nelson R; Baron V; Brixner DI
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative.
    Trygstad TK; Christensen D; Garmise J; Sullivan R; Wegner S
    J Manag Care Pharm; 2005 Sep; 11(7):575-83. PubMed ID: 16137215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy.
    Brixner D; Biltaji E; Bress A; Unni S; Ye X; Mamiya T; Ashcraft K; Biskupiak J
    J Med Econ; 2016; 19(3):213-28. PubMed ID: 26478982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial.
    Elliott LS; Henderson JC; Neradilek MB; Moyer NA; Ashcraft KC; Thirumaran RK
    PLoS One; 2017; 12(2):e0170905. PubMed ID: 28151991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pharmacogenetic testing in patients exposed to polypharmacy: a scoping review.
    Meaddough EL; Sarasua SM; Fasolino TK; Farrell CL
    Pharmacogenomics J; 2021 Aug; 21(4):409-422. PubMed ID: 34140647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting.
    Trygstad TK; Christensen DB; Wegner SE; Sullivan R; Garmise JM
    Clin Ther; 2009 Sep; 31(9):2018-37. PubMed ID: 19843492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Impact of a Pharmacist-Driven Medication Reconciliation Program during Transitions to Long-Term Care and Retirement Homes.
    O'Donnell D; Beaton C; Liang J; Basu K; Hum M; Propp A; Yanni L; Chen Y; Ghafari P
    Healthc Q; 2020 Oct; 23(3):34-40. PubMed ID: 33243364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic testing in psychiatric inpatients with polypharmacy is associated with decreased medication side effects but not via medication changes.
    Collins AR; Kung S; Ho JT; Wright JA; Dammen KC; Johnson EK; Lapid MI; Leung JG
    J Psychiatr Res; 2020 Jul; 126():105-111. PubMed ID: 32442780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report.
    Jessop JP; Russell J; DeJesus A; Bardolia C; Hanna A; Turgeon J; Michaud V; Amin NS
    Am J Case Rep; 2023 Feb; 24():e938850. PubMed ID: 36804920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review center.
    LaFleur J; McBeth C; Gunning K; Oderda L; Steinvoort C; Oderda GM
    J Manag Care Pharm; 2006 Oct; 12(8):677-85. PubMed ID: 17269846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy problems and medication discrepancies during care transitions in super-utilizers.
    Surbhi S; Munshi KD; Bell PC; Bailey JE
    J Am Pharm Assoc (2003); 2016; 56(6):633-642.e1. PubMed ID: 27720595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders.
    Blasco-Fontecilla H
    J Neural Transm (Vienna); 2019 Jan; 126(1):101-107. PubMed ID: 29626260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder.
    Groessl EJ; Tally SR; Hillery N; Maciel A; Garces JA
    J Manag Care Spec Pharm; 2018 Aug; 24(8):726-734. PubMed ID: 30058980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of pharmacogenetic testing in medication reviews in a hospital setting.
    Hjemås BJ; Bøvre K; Bjerknes K; Mathiesen L; Mellingsaeter MCR; Molden E
    Br J Clin Pharmacol; 2023 Oct; 89(10):3116-3125. PubMed ID: 37277227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study.
    Finkelstein J; Friedman C; Hripcsak G; Cabrera M
    Pharmgenomics Pers Med; 2016; 9():107-116. PubMed ID: 27789970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients.
    Niedrig DF; Rahmany A; Heib K; Hatz KD; Ludin K; Burden AM; Béchir M; Serra A; Russmann S
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.
    Plumpton CO; Roberts D; Pirmohamed M; Hughes DA
    Pharmacoeconomics; 2016 Aug; 34(8):771-93. PubMed ID: 26984520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
    Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
    Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D; Brummel AR; Miller DB
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.